Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First approval of an intracranial stent in Japan

This article was originally published in The Gray Sheet

Executive Summary

Tokyo-based Johnson & Johnson/K.K. Medical Co. announces March 23 that Japan's Ministry of Health, Labor and Welfare has approved J&J/Codman's Enterprise vascularreconstruction device and delivery system. The self-expanding stent is used to treat wide-necked intracranial aneurysms. It marks the first approval for an intracranial stent by MHLW. Last year, J&J moved its central nervous system disorder device unit from its Cordis subsidiary to the Codman & Shurtleff unit (1"The Gray Sheet" Jan. 12, 2009)
Advertisement

Related Content

Mergers & Acquisitions In Brief
Mergers & Acquisitions In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT028672

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel